Quarterly report [Sections 13 or 15(d)]

Schedule of Equity Securities (Details)

v3.26.3
Schedule of Equity Securities (Details) - shares
 9 Months Ended
Sep. 30, 2026
Jan. 01, 2026
Dec. 31, 2025
Jan. 01, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Authorized, shares 250,000,000   250,000,000  
Issued, shares 4,930,207   2,660,110  
Pre-funded warrants, shares 1,386,470      
Outstanding, shares 4,930,207   2,660,110  
Authorized, shares 10,000,000   10,000,000  
Issued, shares    
Reserved, shares      
Outstanding, shares    
Issued, shares 10,048,341      
Outstanding, shares 10,048,341   5,424,617  
Nonqualified Inducement Stock Option Grant, shares authorized 15,000      
Authorized, shares 260,417,214      
Issued, shares 15,153,050      
Reserved, shares 242,712      
Outstanding, shares 15,152,959      
2021 Omnibus Equity Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Authorized, shares   133,005   12,588
Reserved, shares 242,712      
Equity Incentive Plan, shares authorized 402,214      
Issued, shares 159,502      
Outstanding, shares 159,411      
Nonqualified Inducement Stock Option Grant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Outstanding, shares 15,000      
Issued, shares 15,000      
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Pre-funded warrants, shares 1,386,470      
Reserved, shares